Yungjin Pharm. Co., Ltd. (003520.KS)
KRW 1989.0
(-2.02%)
KRW 1989.0
(-2.02%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -21.00 KRW | 82.35% |
| 2022 | -120.08 KRW | -89.61% |
| 2021 | -63.33 KRW | -8575.34% |
| 2020 | -0.73 KRW | -102.65% |
| 2019 | 27.50 KRW | 182.43% |
| 2018 | -33.36 KRW | -433.6% |
| 2017 | 10.00 KRW | -58.33% |
| 2016 | 24.00 KRW | 26.32% |
| 2015 | 19.00 KRW | 280.0% |
| 2014 | 5.00 KRW | -92.42% |
| 2013 | 66.00 KRW | 560.0% |
| 2012 | 10.00 KRW | -33.33% |
| 2011 | 15.00 KRW | 193.75% |
| 2010 | -16.00 KRW | 51.28% |
| 2009 | -32.84 KRW | 35.1% |
| 2008 | -50.60 KRW | 61.22% |
| 2007 | -130.49 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 22.38 KRW | 451.33% |
| 2024 Q2 | -7.96 KRW | -135.57% |
| 2024 Q3 | -2.39 KRW | 69.97% |
| 2023 Q4 | -6.37 KRW | -32.99% |
| 2023 Q1 | -0.84 KRW | 99.1% |
| 2023 Q2 | -9.19 KRW | -994.05% |
| 2023 FY | - KRW | 82.35% |
| 2023 Q3 | -4.79 KRW | 47.88% |
| 2022 Q3 | -11.47 KRW | -43.38% |
| 2022 FY | - KRW | -89.61% |
| 2022 Q1 | -8.00 KRW | 14.35% |
| 2022 Q2 | -8.00 KRW | 0.0% |
| 2022 Q4 | -92.92 KRW | -710.11% |
| 2021 Q3 | -21.00 KRW | 10.49% |
| 2021 Q4 | -9.34 KRW | 55.52% |
| 2021 FY | - KRW | -8575.34% |
| 2021 Q1 | -10.00 KRW | 25.09% |
| 2021 Q2 | -23.46 KRW | -134.6% |
| 2020 Q3 | -2.00 KRW | -150.0% |
| 2020 Q4 | -13.35 KRW | -567.5% |
| 2020 FY | - KRW | -102.65% |
| 2020 Q1 | 10.00 KRW | 160.5% |
| 2020 Q2 | 4.00 KRW | -60.0% |
| 2019 Q3 | 16.00 KRW | -15.79% |
| 2019 FY | - KRW | 182.43% |
| 2019 Q1 | 10.00 KRW | 216.55% |
| 2019 Q2 | 19.00 KRW | 90.0% |
| 2019 Q4 | -16.53 KRW | -203.31% |
| 2018 Q2 | -12.00 KRW | -700.0% |
| 2018 Q1 | 2.00 KRW | 127.89% |
| 2018 FY | - KRW | -433.6% |
| 2018 Q4 | -8.58 KRW | 42.8% |
| 2018 Q3 | -15.00 KRW | -25.0% |
| 2017 Q4 | -7.17 KRW | -279.25% |
| 2017 Q2 | 5.00 KRW | -44.44% |
| 2017 Q1 | 9.00 KRW | 608.47% |
| 2017 Q3 | 4.00 KRW | -20.0% |
| 2017 FY | - KRW | -58.33% |
| 2016 Q3 | 9.00 KRW | -10.0% |
| 2016 Q4 | -1.77 KRW | -119.67% |
| 2016 FY | - KRW | 26.32% |
| 2016 Q1 | 5.00 KRW | -34.38% |
| 2016 Q2 | 10.00 KRW | 100.0% |
| 2015 Q2 | 1.00 KRW | -85.71% |
| 2015 Q4 | 7.62 KRW | 154.0% |
| 2015 Q3 | 3.00 KRW | 200.0% |
| 2015 FY | - KRW | 280.0% |
| 2015 Q1 | 7.00 KRW | -14.11% |
| 2014 Q4 | 8.15 KRW | 103.75% |
| 2014 Q3 | 4.00 KRW | 300.0% |
| 2014 Q2 | 1.00 KRW | 112.5% |
| 2014 Q1 | -8.00 KRW | -130.91% |
| 2014 FY | - KRW | -92.42% |
| 2013 FY | - KRW | 560.0% |
| 2013 Q3 | 9.00 KRW | -57.14% |
| 2013 Q2 | 21.00 KRW | 110.0% |
| 2013 Q1 | 10.00 KRW | 28.37% |
| 2013 Q4 | 25.88 KRW | 187.56% |
| 2012 FY | - KRW | -33.33% |
| 2012 Q4 | 7.79 KRW | -44.36% |
| 2012 Q3 | 14.00 KRW | 133.33% |
| 2012 Q2 | 6.00 KRW | 133.56% |
| 2012 Q1 | -17.88 KRW | -980.79% |
| 2011 Q3 | 1.00 KRW | -66.67% |
| 2011 Q1 | 9.00 KRW | 212.92% |
| 2011 Q4 | 2.03 KRW | 103.0% |
| 2011 Q2 | 3.00 KRW | -66.67% |
| 2011 FY | - KRW | 193.75% |
| 2010 Q2 | 18.00 KRW | 157.93% |
| 2010 Q1 | -31.07 KRW | -1081.37% |
| 2010 Q4 | -7.97 KRW | -232.83% |
| 2010 Q3 | 6.00 KRW | -66.67% |
| 2010 FY | - KRW | 51.28% |
| 2009 FY | - KRW | 35.1% |
| 2009 Q4 | -2.63 KRW | 62.96% |
| 2009 Q3 | -7.10 KRW | 55.57% |
| 2009 Q2 | -15.98 KRW | -125.07% |
| 2009 Q1 | -7.10 KRW | 88.44% |
| 2008 Q3 | 1.78 KRW | 100.0% |
| 2008 Q4 | -61.44 KRW | -3551.69% |
| 2008 Q2 | 0.89 KRW | 116.7% |
| 2008 FY | - KRW | 61.22% |
| 2008 Q1 | -5.33 KRW | 79.3% |
| 2007 Q2 | -82.42 KRW | -575.02% |
| 2007 Q3 | 1.61 KRW | 101.95% |
| 2007 Q1 | -12.21 KRW | 0.0% |
| 2007 Q4 | -25.75 KRW | -1699.38% |
| 2007 FY | - KRW | 0.0% |